Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Acta Medica Okayama|November 10, 2022
COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung AdenocarcinomaTaku Noumi, Hiromi Watanabe, Kiichiro Ninomiya, et al.
Chest|May 21, 2026
Impact of pre-existing schizophrenia spectrum disorder on the receipt of surgery and other treatments for non-small cell lung cancer: A multicenter nationwide cohort study in JapanYuto Yamada, Masaki Fujiwara, Taisuke Ishii, et al.
Acta Medica Okayama|August 27, 2025
A Rare Presentation of Pneumonic-Type Adenocarcinoma Hidden behind EmpyemaSatoru Senoo, Eito Niman, Ryoko Tsuji, et al.
Cancer Immunology, Immunotherapy : CII|July 11, 2020
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitorsEiki Ichihara, Daijiro Harada, Koji Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|February 8, 2025
Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell linesTatsuya Nishi, Ayako Morita, Naofumi Hara, et al.
International Journal of Clinical Oncology|June 22, 2015
Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201Kiichiro Ninomiya, Katsuyuki Hotta, Akiko Hisamoto-Sato, et al.
Scientific Reports|January 20, 2025
Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancerTadahiro Kuribayashi, Rie Kinoshita, Kiichiro Ninomiya, et al.
Respiratory Medicine Case Reports|June 1, 2022
Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolizationMasataka Taoka, Go Makimoto, Noriyuki Umakoshi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2021
The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expressionNobuaki Ochi, Eiki Ichihara, Nagio Takigawa, et al.
Japanese Journal of Clinical Oncology|October 13, 2020
Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancerShinobu Hosokawa, Eiki Ichihara, Akihiro Bessho, et al.
Pageof 18